Metraipolis › archive › dc_48174241df3d

Paeoniflorin Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by SYK/SH3BP2 Signaling Pathway — Europe PMC PMID:41635508

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41635508
DOI
10.34133/research.1100
License (as archived)
solo-consultazione
Archived
2026-11-06T08:01:55.344Z
SHA-256 of the archived text
bf8f6abb7ff13c991754fa6e3f5f0b3db4cef3203f190520ee5bc82d9f1b11cf
Stable URL of this page
https://metraipolis.com/documento/dc_48174241df3d

How to cite

Paeoniflorin Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by SYK/SH3BP2 Signaling Pathway — Europe PMC PMID:41635508 — Europe PMC (en), https://europepmc.org/article/MED/41635508 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48174241df3d (Metraipolis archive dc_48174241df3d, sha256 bf8f6abb7ff13c991754fa6e3f5f0b3db4cef3203f190520ee5bc82d9f1b11cf)
BibTeX
@misc{dc48174241df3d,
  title = {Paeoniflorin Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by SYK/SH3BP2 Signaling Pathway — Europe PMC PMID:41635508},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41635508},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48174241df3d; sha256 bf8f6abb7ff13c991754fa6e3f5f0b3db4cef3203f190520ee5bc82d9f1b11cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41635508. Agents can read the archived copy with the MCP tool read_document.